Skip to main content

Advertisement

SpringerLink
Log in

Frequency of extracolonic tumors in Brazilian families with Lynch syndrome: analysis of a hereditary colorectal cancer institutional registry

  • Published:
Familial Cancer Aims and scope Submit manuscript

Abstract

Lynch syndrome (LS) is caused by inherited germline mutations in mismatch repair (MMR) genes. It is one of the commonest forms of inherited predisposition to colorectal cancer (CRC), accounting for 2–5% of all CRC. LS is characterized by early age of onset, with a tendency for multiplicity and an increased risk for extra-colonic tumors at particular sites. In this study we have evaluated the frequency of extra-colonic tumors in 60 unrelated LS families fulfilling the Amsterdam criteria (ACI. ACII) from the Oncotree database of the Hereditary Colorectal Cancer Registry of the AC Camargo Hospital. All families’ pedigree was extensively analyzed, varying from 2 to 6 generations with a total of 2,095 individuals evaluated. As expected, colorectal cancer was the most frequent tumor in the families (334 cases). We found 200 extracolonic tumors among all individuals with a higher ratio in women (123 cases) than men (77 cases). By far, breast cancer (32 cases) was the most frequent extracolonic manifestation in women followed by endometrial (20 cases) and uterine cervix cancer (20 cases). For man, prostate (16 cases) and stomach (12 cases) cancer were the most frequent extracolonic tumors. It is well know that establishing the diagnosis is challenging and requires knowledge and surveillance. Thus, recognition of individuals and families with hereditary predisposition to cancer according to clinical and molecular features, combined with intensive surveillance and management programs, can contribute substantially to improve results related to the diagnosis and characterization of LS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

Abbreviations

HNPCC:

Hereditary non-polyposis colorectal cancer

CRC:

Colorectal cancer

MMR:

Mismatch repair gene

LS:

Lynch syndrome

ACI:

Amsterdam criteria I

ACII:

Amsterdam criteria II

References

  1. Woolf CM (1958) A genetic study of carcinoma of the large intestine. Am J Hum Genet 10(1):42–47

    CAS  PubMed  Google Scholar 

  2. Lovett E (1976) Family studies in cancer of the colon and rectum. Br J Surg 63(1):13–18

    Article  CAS  PubMed  Google Scholar 

  3. Macklin MT (1960) Inheritance of cancer of the stomach and large intestine in man. J Natl Cancer Inst 24:551–571

    CAS  PubMed  Google Scholar 

  4. Duncan JL, Kyle J (1982) Family incidence of carcinoma of the colon and rectum in north-east Scotland. Gut 23(2):169–171

    Article  CAS  PubMed  Google Scholar 

  5. Potter JD (1999) Colorectal cancer: molecules and populations. J Natl Cancer Inst 91(11):916–932

    Article  CAS  PubMed  Google Scholar 

  6. Warthin AS (1913) Heredity with reference to carcinoma as shown by the study of the cases examined in the pathological laboratory of the University of Michigan. Arch Int Med 12:546–555

    Google Scholar 

  7. Savage D (1956) A family history of uterine and gastro-intestinal cancer. Br Med J 2(4988):341–343

    Article  CAS  PubMed  Google Scholar 

  8. Kluge T (1964) Familial cancer of the colon. Acta Chir Scand 127:392–398

    CAS  PubMed  Google Scholar 

  9. Lynch HT, Krush AJ (1971) Cancer family “G” revisited: 1895–1970. Cancer 27(6):1505–1511

    Article  CAS  PubMed  Google Scholar 

  10. Boland CR, Troncale FJ (1984) Familial colonic cancer without antecedent polyposis. Ann Intern Med 100(5):700–701

    CAS  PubMed  Google Scholar 

  11. Ministry of Health/National Institute of Cancer-Inca (2010) Available from: http://www1.inca.gov.br/estimativa/2010/index.asp?link=tabelaestados.asp&UF=BR. Cited 1 May 2010

  12. Geary J, Sasieni P, Houlston R et al (2008) Gene-related cancer spectrum in families with hereditary non-polyposis colorectal cancer (HNPCC). Fam Cancer 7(2):163–172

    Article  CAS  PubMed  Google Scholar 

  13. Lynch HT, Ens J, Lynch JF, Watson P (1988) Tumor variation in three extended Lynch syndrome II kindreds. Am J Gastroenterol 83(7):741–747

    CAS  PubMed  Google Scholar 

  14. Lynch HT, Lynch JF (1993) The Lynch syndromes. Curr Opin Oncol 5(4):687–696

    Article  CAS  PubMed  Google Scholar 

  15. Lin KM, Shashidharan M, Ternent CA et al (1998) Colorectal and extracolonic cancer variations in MLH1/MSH2 hereditary non-polyposis colorectal cancer kindreds and the general population. Dis Colon Rectum 41(4):428–433

    Article  CAS  PubMed  Google Scholar 

  16. Watson P, Riley B (2005) The tumor spectrum in the Lynch syndrome. Fam Cancer 4(3):245–248

    Article  PubMed  Google Scholar 

  17. Vasen HF, Mecklin JP, Khan PM, Lynch HT (1991) The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 34(5):424–425

    Article  CAS  PubMed  Google Scholar 

  18. Vasen HF, Watson P, Mecklin JP, Lynch HT (1999) New clinical criteria for hereditary non-polyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 116(6):1453–1456

    Article  CAS  PubMed  Google Scholar 

  19. Lynch HT, Smyrk TC, Watson P et al (1993) Genetics, natural history, tumor spectrum, and pathology of hereditary non-polyposis colorectal cancer: an updated review. Gastroenterology 104(5):1535–1549

    CAS  PubMed  Google Scholar 

  20. Marra G, Boland CR (1995) Hereditary non-polyposis colorectal cancer: the syndrome, the genes, and historical perspectives. J Natl Cancer Inst 87(15):1114–1125

    Article  CAS  PubMed  Google Scholar 

  21. Lynch HT, Smyrk T (1996) Hereditary non-polyposis colorectal cancer (Lynch syndrome): an updated review. Cancer 78(6):1149–1167

    Article  CAS  PubMed  Google Scholar 

  22. Lynch HT, Smyrk T, Lynch J (1997) An update of HNPCC (Lynch syndrome). Cancer Genet Cytogenet 93(1):84–99

    Article  CAS  PubMed  Google Scholar 

  23. Peltomäki P, Vasen HF (1997) Mutations predisposing to hereditary non-polyposis colorectal cancer: database and results of a collaborative study. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer. Gastroenterology 113(4):1146–1158

    Article  PubMed  Google Scholar 

  24. Giardiello FM (1997) Genetic testing in hereditary colorectal cancer. JAMA 278(15):1278–1281

    Article  CAS  PubMed  Google Scholar 

  25. Bai YQ, Akiyama Y, Nagasaki H et al (1999) Predominant germ-line mutation of the hMSH2 gene in Japanese hereditary non-polyposis colorectal cancer kindreds. Int J Cancer 82(4):512–515

    Article  CAS  PubMed  Google Scholar 

  26. Kim JC, Kim HC, Roh SA et al (2001) hMLH1 and hMSH2 mutations in families with familial clustering of gastric cancer and hereditary non-polyposis colorectal cancer. Cancer Detect Prev 25(6):503–510

    CAS  PubMed  Google Scholar 

  27. Rossi BM, Lopes A, Oliveira Ferreira F et al (2002) hMLH1 and hMSH2 gene mutation in Brazilian families with suspected hereditary non-polyposis colorectal cancer. Ann Surg Oncol 9(6):555–561

    PubMed  Google Scholar 

  28. Oliveira Ferreira F, Napoli Ferreira CC, Rossi BM et al (2004) Frequency of extracolonic tumors in hereditary non-polyposis colorectal cancer (HNPCC) and familial colorectal cancer (FCC) Brazilian families: An analysis by a Brazilian Hereditary Colorectal Cancer Institutional Registry. Fam Cancer 3(1):41–47

    Article  PubMed  Google Scholar 

  29. Henderson TO, Amsterdam A, Bhatia S et al (2010) Systematic review: surveillance for breast cancer in women treated with chest radiation for childhood, adolescent, or young adult cancer. Ann Intern Med 152(7):444–455

    PubMed  Google Scholar 

  30. Vasen HF, Morreau H, Nortier JW (2001) Is breast cancer part of the tumor spectrum of hereditary non-polyposis colorectal cancer? Am J Hum Genet 68(6):1533–1535

    Article  CAS  PubMed  Google Scholar 

  31. Westenend PJ, Schütte R, Hoogmans MM et al (2005) Breast cancer in an MSH2 gene mutation carrier. Hum Pathol 36(12):1322–1326

    Article  CAS  PubMed  Google Scholar 

  32. Risinger JI, Barrett JC, Watson P et al (1996) Molecular genetic evidence of the occurrence of breast cancer as an integral tumor in patients with the hereditary non-polyposis colorectal carcinoma syndrome. Cancer 77(9):1836–1843

    Article  CAS  PubMed  Google Scholar 

  33. Nelson CL, Sellers TA, Rich SS et al (1993) Familial clustering of colon, breast, uterine, and ovarian cancers as assessed by family history. Genet Epidemiol 10(4):235–244

    Article  CAS  PubMed  Google Scholar 

  34. de Leeuw WJ, van Puijenbroek M, Tollenaar RA et al (2003) Correspondence re: A. Müller et al., Exclusion of breast cancer as an integral tumor of hereditary non-polyposis colorectal cancer. Cancer Res., 62: 1014–1019, 2002. Cancer Res 63(5):1148–1149

    PubMed  Google Scholar 

  35. Boyd J, Rhei E, Federici MG et al (1999) Male breast cancer in the hereditary non-polyposis colorectal cancer syndrome. Breast Cancer Res Treat 53(1):87–91

    Article  CAS  PubMed  Google Scholar 

  36. Scott RJ, McPhillips M, Meldrum CJ et al (2001) Hereditary non-polyposis colorectal cancer in 95 families: differences and similarities between mutation-positive and mutation-negative kindreds. Am J Hum Genet 68(1):118–127

    Article  CAS  PubMed  Google Scholar 

  37. Müller A, Edmonston TB, Corao DA et al (2002) Exclusion of breast cancer as an integral tumor of hereditary non-polyposis colorectal cancer. Cancer Res 62(4):1014–1019

    PubMed  Google Scholar 

  38. Itoh H, Houlston RS, Harocopos C, Slack J (1990) Risk of cancer death in first-degree relatives of patients with hereditary non-polyposis cancer syndrome (Lynch type II): a study of 130 kindreds in the United Kingdom. Br J Surg 77(12):1367–1370

    Article  CAS  PubMed  Google Scholar 

  39. Watson P, Lynch HT (1993) Extracolonic cancer in hereditary nonpolyposis colorectal cancer. Cancer 71(3):677–685

    Article  CAS  PubMed  Google Scholar 

  40. Aarnio M, Sankila R, Pukkala E et al (1999) Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer 81(2):214–218

    Article  CAS  PubMed  Google Scholar 

  41. Jass JR (2000) Pathology of hereditary non-polyposis colorectal cancer. Ann NY Acad Sci 910:62–73

    Article  CAS  PubMed  Google Scholar 

  42. Jensen UB, Sunde L, Timshel S et al (2010) Mismatch repair defective breast cancer in the hereditary non-polyposis colorectal cancer syndrome. Breast Cancer Res Treat 120:777–782

    Article  CAS  PubMed  Google Scholar 

  43. Meijers-Heijboer H, Wijnen J, Vasen H et al (2003) The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype. Am J Hum Genet 72(5):1308–1314

    Article  CAS  PubMed  Google Scholar 

  44. Parc Y, Boisson C, Thomas G et al (2003) Cancer risk in 348 French MSH2 or MLH1 gene carriers. J Med Genet 40(3):208–213

    Article  CAS  PubMed  Google Scholar 

  45. Aarnio M, Mecklin JP, Aaltonen LA et al (1995) Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. Int J Cancer 64(6):430–433

    Article  CAS  PubMed  Google Scholar 

  46. Vasen HF, Stormorken A, Menko FH et al (2001) MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary non-polyposis colorectal cancer families. J Clin Oncol 19(20):4074–4080

    CAS  PubMed  Google Scholar 

  47. Watson P, Lynch HT (2001) Cancer risk in mismatch repair gene mutation carriers. Fam Cancer 1(1):57–60

    Article  CAS  PubMed  Google Scholar 

  48. Goodfellow PJ, Buttin BM, Herzog TJ et al (2003) Prevalence of defective DNA mismatch repair and MSH6 mutation in an unselected series of endometrial cancers. Proc Natl Acad Sci USA 100(10):5908–5913

    Article  CAS  PubMed  Google Scholar 

  49. Wagner A, Barrows A, Wijnen JT et al (2003) Molecular analysis of hereditary non-polyposis colorectal cancer in the United States: high mutation detection rate among clinically selected families and characterization of an American founder genomic deletion of the MSH2 gene. Am J Hum Genet 72(5):1088–1100

    Article  CAS  PubMed  Google Scholar 

  50. Franco EL, Villa LL, Ruiz A et al (1995) Transmission of cervical human papillomavirus infection by sexual activity: differences between low and high oncogenic risk types. J Infect Dis 172(3):756–763

    CAS  PubMed  Google Scholar 

  51. Kjaer SK, Chackerian B, van den Brule AJ et al (2001) High-risk human papillomavirus is sexually transmitted: evidence from a follow-up study of virgins starting sexual activity (intercourse). Cancer Epidemiol Biomark Prev 10(2):101–106

    CAS  Google Scholar 

  52. Peyton CL, Gravitt PE, Hunt WC et al (2001) Determinants of genital human papillomavirus detection in a US population. J Infect Dis 183(11):1554–1564

    Article  CAS  PubMed  Google Scholar 

  53. Burchell AN, Winer RL, de Sanjosé S et al (2006) Chapter 6: epidemiology and transmission dynamics of genital HPV infection. Vaccine 24(Suppl 3):S52–S61

    Article  Google Scholar 

  54. Goecke T, Schulmann K, Engel C et al (2006) Genotype-phenotype comparison of German MLH1 and MSH2 mutation carriers clinically affected with Lynch syndrome: a report by the German HNPCC Consortium. J Clin Oncol 24(26):4285–4292

    Article  CAS  PubMed  Google Scholar 

  55. Park YJ, Shin KH, Park JG (2000) Risk of gastric cancer in hereditary non-polyposis colorectal cancer in Korea. Clin Cancer Res 6(8):2994–2998

    CAS  PubMed  Google Scholar 

  56. Zhang Y, Sheng J, Li S et al (2005) Clinical phenotype and prevalence of hereditary non-polyposis colorectal cancer syndrome in Chinese population. World J Gastroenterol 11(10):1481–1488

    PubMed  Google Scholar 

  57. Lynch HT, Grady W, Suriano G et al (2005) Gastric cancer: new genetic developments. J Surg Oncol 90(3):114–133 (discussion 133)

    Article  CAS  PubMed  Google Scholar 

  58. Gayther SA, Gorringe KL, Ramus SJ et al (1998) Identification of germ-line E-cadherin mutations in gastric cancer families of European origin. Cancer Res 58(18):4086–4089

    CAS  PubMed  Google Scholar 

  59. Guilford P, Hopkins J, Harraway J et al (1998) E-cadherin germline mutations in familial gastric cancer. Nature 392(6674):402–405

    Article  CAS  PubMed  Google Scholar 

  60. Bevan S, Houlston RS (1999) Genetic predisposition to gastric cancer. QJM 92(1):5–10

    Article  CAS  PubMed  Google Scholar 

  61. Gylling A, Abdel-Rahman WM, Juhola M et al (2007) Is gastric cancer part of the tumour spectrum of hereditary non-polyposis colorectal cancer? A molecular genetic study. Gut 56(7):926–933

    Article  CAS  PubMed  Google Scholar 

  62. Mueller-Koch Y, Vogelsang H, Kopp R et al (2005) Hereditary non-polyposis colorectal cancer: clinical and molecular evidence for a new entity of hereditary colorectal cancer. Gut 54(12):1733–1740

    Article  CAS  PubMed  Google Scholar 

  63. Wijnen J, Khan PM, Vasen H et al (1997) Hereditary nonpolyposis colorectal cancer families not complying with the Amsterdam criteria show extremely low frequency of mismatch-repair-gene mutations. Am J Hum Genet 61(2):329–335

    Article  CAS  PubMed  Google Scholar 

  64. Nyström-Lahti M, Wu Y, Moisio AL et al (1996) DNA mismatch repair gene mutations in 55 kindreds with verified or putative hereditary non-polyposis colorectal cancer. Hum Mol Genet 5(6):763–769

    Article  PubMed  Google Scholar 

  65. Katballe N, Juul S, Christensen M et al (2001) Patient accuracy of reporting on hereditary non-polyposis colorectal cancer-related malignancy in family members. Br J Surg 88(9):1228–1233

    Article  CAS  PubMed  Google Scholar 

  66. Murff HJ, Spigel DR, Syngal S (2004) Does this patient have a family history of cancer? An evidence-based analysis of the accuracy of family cancer history. JAMA 292(12):1480–1489

    Article  CAS  PubMed  Google Scholar 

  67. Liu B, Parsons R, Papadopoulos N et al (1996) Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat Med 2(2):169–174

    Article  CAS  PubMed  Google Scholar 

  68. Renkonen E, Zhang Y, Lohi H et al (2003) Altered expression of MLH1, MSH2, and MSH6 in predisposition to hereditary nonpolyposis colorectal cancer. J Clin Oncol 21(19):3629–3637

    Article  CAS  PubMed  Google Scholar 

  69. Lindor NM, Rabe K, Petersen GM et al (2005) Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. JAMA 293(16):1979–1985

    Article  CAS  PubMed  Google Scholar 

  70. Lynch HT, Lynch PM, Lanspa SJ et al (2009) Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications. Clin Genet 76(1):1–18

    Article  CAS  PubMed  Google Scholar 

  71. Roy HK, Lynch HT (2003) Diagnosing Lynch syndrome: is the answer in the mouth? Gut 52(12):1665–1667

    Article  CAS  PubMed  Google Scholar 

  72. de la Chapelle A (2005) The incidence of Lynch syndrome. Fam Cancer 4(3):233–237

    Article  Google Scholar 

Download references

Acknowledgment

Supported by Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq).

Author information

Authors and Affiliations

  1. Research Center of the AC Camargo Hospital, Fundação Antônio Prudente, Rua Taguá No. 440, São Paulo, SP, 01508-010, Brazil

    Felipe Carneiro da Silva, Ligia Petrolini de Oliveira & Mev Dominguez Valentin

  2. Hereditary Colorectal Cancer Registry of the A.C. Camargo Hospital, Fundação Antônio Prudente, São Paulo, SP, Brazil

    Érika Monteiro Santos, Wilson Toshihiko Nakagawa, Samuel Aguiar Junior, Benedito Mauro Rossi & Fábio de Oliveira Ferreira

Authors
  1. Felipe Carneiro da Silva
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ligia Petrolini de Oliveira
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Érika Monteiro Santos
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Wilson Toshihiko Nakagawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Samuel Aguiar Junior
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Mev Dominguez Valentin
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Benedito Mauro Rossi
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Fábio de Oliveira Ferreira
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Felipe Carneiro da Silva.

Rights and permissions

Reprints and permissions

About this article

Cite this article

da Silva, F.C., de Oliveira, L.P., Santos, É.M. et al. Frequency of extracolonic tumors in Brazilian families with Lynch syndrome: analysis of a hereditary colorectal cancer institutional registry. Familial Cancer 9, 563–570 (2010). https://doi.org/10.1007/s10689-010-9373-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10689-010-9373-2

Keywords

Search

Navigation